Transfer for primary angioplasty: Who and how?

Heart

Volumn 88, Issue 6, 2002, Pages 570-572

  Dalby, M ^a   Montalescot, Gilles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANGIOPLASTY; BLOOD CLOT LYSIS; CLINICAL TRIAL; DRUG INDICATION; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEMODYNAMIC MONITORING; HUMAN; META ANALYSIS; PATIENT TRANSPORT; PRIORITY JOURNAL; REVASCULARIZATION; SHORT SURVEY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036897625     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.6.570     Document Type: Short Survey

References (14)

1. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 1997;278:2093-8.
2. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000;21:823-31.
3. The Danish multicenter randomized study on thrombolytic therapy versus acute coronary angioplasty in acute myocardial infarction. (DANAMI-2). 51st Annual Scientific Sessions of the American College of Cardiology. Atlanta, March 2002.
4. Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for infarction in patients presenting to hospitals without on-site cardiac surgery: A randomized controlled trial. JAMA 2002;287:1943-51.
5. Bonnefoy E, Lepostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomised study. Lancet 2002;360:825-32.
6. Zijlstra F, Patel A, Jones M, et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate [2-4 h) and late [>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardia infarction. Eur Heart J 2002;23:550-7.
7. Woollard M, Smith A, Elwood P. Pre-hospital aspirin for suspected myocardial infarction and acute coronary syndromes: A headache for paramedics? Emerg Med J 2001;18:478-81.
8. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-33.
9. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-66.
10. Savcic M, Hauert J, Bachmann F, et al. Clopidogrel loading dose regimens: Kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost 1999;25(suppl 2):15-9.
11. Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999;99:2720-32.
12. Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement af coronary-artery stents in acute myocardial infarction. Circulation 1998;98:2695-701.
13. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-903.
14. Cutlip DE, Cove CJ, Irons D, et al. Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes. Am J Cardiol 2001;88:A6, 62-4.